Title: « Refining risk stratification using CMR in patients with hypertrophic cardiomyopathy ». Abstract: Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, characterized by ventricular hypertrophy, myocyte disarray, and interstitial fibrosis, often resulting from sarcomere gene variants. Patients experience adverse events such as heart failure (HF), stroke, arrythmias and sudden cardiac death (SCD) leading to […]